Table 2.
Results of clinical evaluations after treatment
| I: rSK schedule A | II: rSK schedule B | III: Hydrocortisone | P value | |
| n | 170 | 170 | 170 | |
| Response after 3 d | 117 (68.8) | 109 (64.1) | 12 (7.1) | < 0.0011 |
| Response after 5 d (95%CI) | 156 (91.8) (87.3-96.2) | 155 (91.2) (86.6-95.7) | 46 (27.1) (20.1-34.0) | < 0.0011 |
| Difference with III (95%CI) | 64.6 (56.7-72.2) | 63.9 (55.7-72.0) | ||
| Response after 10 d | 165 (97.1) | 159 (93.5) | 114 (67.1) | < 0.0011 |
| Days to response, median (95%CI) | 3 (2.9-3.1) | 3 (2.9-3.1) | 10 (9.3-10.7) | < 0.0012 |
1
Likelihood ratio χ2;
2
Log-rank test. Main outcome are represented in bold. rSK: Recombinant streptokinase.